SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-008339
Filing Date
2017-08-08
Accepted
2017-08-08 16:40:15
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx10-qq22017.htm 10-Q 1223700
2 EXHIBIT 31.1 ptgx10-qq2ex311.htm EX-31.1 14140
3 EXHIBIT 31.2 ptgx10-qq2ex312.htm EX-31.2 14152
4 EXHIBIT 32.1 ptgx10-qq2ex321.htm EX-32.1 11722
  Complete submission text file 0001628280-17-008339.txt   5110667

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptgx-20170630.xml EX-101.INS 938231
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptgx-20170630.xsd EX-101.SCH 41716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptgx-20170630_cal.xml EX-101.CAL 63394
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptgx-20170630_def.xml EX-101.DEF 186225
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptgx-20170630_lab.xml EX-101.LAB 531766
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptgx-20170630_pre.xml EX-101.PRE 304723
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 171015356
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1